Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Mutation screening of CHD5 in melanoma-prone families linked to 1p36 revealed no deleterious coding or splice site changes.

Ng D, Yang XR, Tucker MA, Goldstein AM.

BMC Res Notes. 2008 Sep 19;1:86. doi: 10.1186/1756-0500-1-86.

2.

Preliminary evidence for involvement of the tumour suppressor gene CHD5 in a family with cutaneous melanoma.

Lang J, Tobias ES, Mackie R.

Br J Dermatol. 2011 May;164(5):1010-6. doi: 10.1111/j.1365-2133.2011.10223.x.

PMID:
21250965
3.

Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations.

Goldstein AM, Struewing JP, Chidambaram A, Fraser MC, Tucker MA.

J Natl Cancer Inst. 2000 Jun 21;92(12):1006-10.

4.

Inherited susceptibility to several cancers but absence of linkage between dysplastic nevus syndrome and CDKN2A in a melanoma family with a mutation in the CDKN2A (P16INK4A) gene.

Puig S, Ruiz A, Castel T, Volpini V, Malvehy J, Cardellach F, Lynch M, Mascaro JM, Estivill X.

Hum Genet. 1997 Dec;101(3):359-64.

PMID:
9439668
5.

Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) on chromosome 1p, and evidence for genetic heterogeneity.

Goldstein AM, Dracopoli NC, Ho EC, Fraser MC, Kearns KS, Bale SJ, McBride OW, Clark WH Jr, Tucker MA.

Am J Hum Genet. 1993 Mar;52(3):537-50.

6.

Gene-covariate interaction between dysplastic nevi and the CDKN2A gene in American melanoma-prone families.

Goldstein AM, Martinez M, Tucker MA, Demenais F.

Cancer Epidemiol Biomarkers Prev. 2000 Sep;9(9):889-94.

7.

Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity.

Goldstein AM, Dracopoli NC, Engelstein M, Fraser MC, Clark WH Jr, Tucker MA.

Am J Hum Genet. 1994 Mar;54(3):489-96.

8.

Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma.

Platz A, Hansson J, Månsson-Brahme E, Lagerlof B, Linder S, Lundqvist E, Sevigny P, Inganäs M, Ringborg U.

J Natl Cancer Inst. 1997 May 21;89(10):697-702.

9.

Hereditary malignant melanoma is not linked to the HLA complex on chromosome 6.

Bale SJ, Greene MH, Murray C, Goldin LR, Johnson AH, Mann D.

Int J Cancer. 1985 Oct 15;36(4):439-43.

PMID:
4044054
10.

CDKN2A mutation in a non-FAMMM kindred with cancers at multiple sites results in a functionally abnormal protein.

Sun S, Pollock PM, Liu L, Karimi S, Jothy S, Milner BJ, Renwick A, Lassam NJ, Hayward NK, Hogg D, Narod SA, Foulkes WD.

Int J Cancer. 1997 Nov 14;73(4):531-6.

11.

Two-locus linkage analysis of cutaneous malignant melanoma/dysplastic nevi.

Goldstein AM, Goldin LR, Dracopoli NC, Clark WH Jr, Tucker MA.

Am J Hum Genet. 1996 May;58(5):1050-6.

12.

Analysis of mutations in the p16/CDKN2A gene in sporadic and familial melanoma in the Polish population.

Lamperska K, Karezewska A, Kwiatkowska E, Mackiewicz A.

Acta Biochim Pol. 2002;49(2):369-76.

13.

CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia.

Ruiz A, Puig S, Malvehy J, Lázaro C, Lynch M, Gimenez-Arnau AM, Puig L, Sánchez-Conejo J, Estivill X, Castel T.

J Med Genet. 1999 Jun;36(6):490-3.

14.

[Clinico-genetic aspects of cutaneous melanoma. II. Interconnection and pathogenetic commonality with dysplastic nevus syndrome].

Kharkevich GIu, Kazubskaia TP, Agapova RK, Musatov VK, Trubnikov VI, Demidov LV, Gar'kavtseva RF.

Genetika. 1995 Nov;31(11):1562-5. Russian.

PMID:
8666223
15.

Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families.

Chaudru V, Chompret A, Bressac-de Paillerets B, Spatz A, Avril MF, Demenais F.

J Natl Cancer Inst. 2004 May 19;96(10):785-95.

16.

Hereditary melanoma in Australia. Variable association with dysplastic nevi and absence of genetic linkage to chromosome 1p.

Kefford RF, Salmon J, Shaw HM, Donald JA, McCarthy WH.

Cancer Genet Cytogenet. 1991 Jan;51(1):45-55.

PMID:
1670625
17.

CDKN2A point mutations D153spl(c.457G>T) and IVS2+1G>T result in aberrant splice products affecting both p16INK4a and p14ARF.

Rutter JL, Goldstein AM, Dávila MR, Tucker MA, Struewing JP.

Oncogene. 2003 Jul 10;22(28):4444-8.

PMID:
12853981
18.

Melanocytic nevi, dysplastic nevi, and malignant melanoma in children from melanoma-prone families.

Novakovic B, Clark WH Jr, Fears TR, Fraser MC, Tucker MA.

J Am Acad Dermatol. 1995 Oct;33(4):631-6.

PMID:
7673498
19.

Germline splicing mutations of CDKN2A predispose to melanoma.

Loo JC, Liu L, Hao A, Gao L, Agatep R, Shennan M, Summers A, Goldstein AM, Tucker MA, Deters C, Fusaro R, Blazer K, Weitzel J, Lassam N, Lynch H, Hogg D.

Oncogene. 2003 Sep 25;22(41):6387-94.

PMID:
14508519
20.

Age at diagnosis and transmission of invasive melanoma in 23 families with cutaneous malignant melanoma/dysplastic nevi.

Goldstein AM, Fraser MC, Clark WH Jr, Tucker MA.

J Natl Cancer Inst. 1994 Sep 21;86(18):1385-90.

PMID:
8072031
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk